Sphingosine 1-phosphate signal survival and mitogenesis are mediated by lipid-stereospecific binding of triacylglycerol-rich lipoproteins

Cellular and Molecular Life Sciences

Volumn 60, Issue 12, 2003, Pages 2757-2766

  Pacheco, Y M ^a   Abia, R ^a   Olivera, A ^b   Spiegel, S ^b   Ruiz Gutierrez, V ^a   Muriana, F J G ^a  

^a INSTITUTO DE LA GRASA   (Spain)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Postprandial metabolism; Sphingolipid; Triacylglycerol rich lipoprotein; VSMC

Indexed keywords

FATTY ACID; LIPOPROTEIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; TRIACYLGLYCEROL;

ARTICLE; ATHEROGENESIS; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID HYDROLYSIS; LIPID METABOLISM; MITOGENESIS; NORMAL HUMAN; POSTPRANDIAL STATE; PROTEIN LIPID INTERACTION; SIGNAL TRANSDUCTION; STEREOSPECIFICITY;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; DOXORUBICIN; HUMANS; LIPOPROTEINS; LYSOPHOSPHOLIPIDS; MITOSIS; MYOCYTES, SMOOTH MUSCLE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SPHINGOMYELINS; SPHINGOSINE; TIME FACTORS; TRIGLYCERIDES;

EID: 0347991766     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3323-1     Document Type: Article

References (49)

1. Bene H., Lasky D. and Ntambi J. M. (2001) Cloning and characterization of the human stearoyl-CoA desaturase gene promoter: transcriptional activation by sterol regulatory element binding protein and repression by polyunsaturated fatty acids and cholesterol. Biochem. Biophys. Res. Commun. 284: 1194-1198
2. Kim Y. C. and Ntambi J. M. (1999) Regulation of stearoyl-CoA desaturase genes: role in cellular metabolism and preadipocyte differentiation. Biochem. Biophys. Res. Commun 266: 1-4
3. Ntambi J. M. (1999) Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid. Res. 40: 1549-1558
4. Kris-Etherton P. M., Pearson T. A., Wan Y., Hargrove R. L., Moriarty K., Fishell V. et al. (1999) High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am. J. Clin. Nutr. 70: 1009-1015
5. Massaro M., Carluccio M. and De Caterina R. (1999) Direct vascular antiatherogenic effects of oleic acid: a clue to the cardioprotective effects of the Mediterranean diet. Cardiologia 44: 507-513
6. Montoya M. T., Porres A., Serrano S., Fruchart J. C., Mata P., Gerique J. A. et al. (2002) Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity. Am. J. Clin. Nutr. 75: 484-491
7. Muriana F. J. G., Villar J. and Ruiz-Gutierrez V. (1997) Intake of olive oil can modulate the transbilayer movement of human erythrocyte membrane cholesterol. Cell. Mol. Life Sci. 53: 442-446
8. Roche H. M. and Gibney M. J. (2000) The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc. Risk 7: 317-324
9. Roche H. M., Zampelas A., Knapper J. M., Webb D., Brooks C., Jackson K. G. et al. (1998) Effect of long-term olive oil dietary intervention on postprandial triacylglycerol and factor VII metabolism. Am. J. Clin. Nutr. 68: 552-560
10. Malloy M. J. and Kane J. P. (2001) A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv. Intern. Med. 47: 111-136
11. Parks E. J. (2001) Recent findings in the study of postprandial lipemia. Curr. Atheroscler. Rep. 3: 462-470
12. Patsch W., Esterbauer H., Foger B. and Patsch J. R. (2000) Postprandial lipemia and coronary risk. Curr. Atheroscler. Rep. 2: 232-242
13. Yu K. C. and Cooper A. D. (2001) Postprandial lipoproteins and atherosclerosis. Front. Biosci. 6: D332-D354
14. Heeren J. and Beisiegel U. (2001) Intracellular metabolism of triglyceride-rich lipoproteins. Curr. Opin. Lipidol. 12: 255-260
15. Ross R. (1999) Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340: 115-126
16. Abia R., Perona J. S., Pacheco Y. M., Montero E., Muriana F. J. G. and Ruiz-Gutierrez V. (1999) Postprandial triacylglycerols from dietary virgin olive oil are selectively cleared in humans. J. Nutr. 129: 2184-2191
17. Abia R., Pacheco Y. M., Perona J. S., Montero E., Muriana F. J. G. and Ruiz-Gutierrez V. (2001) The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J. Nutr. 131: 59-65
18. Pacheco Y. M., Abia R., Perona J. S., Reina M., Ruiz-Gutierrez V. and Muriana F. J. G. (2001) Triacylglycerol-rich lipoproteins interact with human vascular cells in a lipid-dependent fashion. J. Agr. Food Chem. 49: 5653-5661
19. Pacheco Y. M., Abia R., Perona J. S., Meier E., Montero E., Ruiz-Gutierrez V. et al. (2002) Triacylglycerol-rich lipoproteins trigger the phosphorylation of extracellular-signal regulated kinases in vascular cells. Life Sci. 71: 1351-1360
20. Auge N., Escargueil-Blanc I., Lajoie-Mazenc I., Suc I., Andrieu-Abadie N., Pieraggi M. T. et al. (1998) Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J. Biol. Chem. 273: 12893-12900
21. Auge N., Nikolova-Karakashian M., Carpentier S., Parthasarathy S., Negre-Salvayre A., Salvayre R. et al. (1999) Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase. J. Biol. Chem. 274: 21533-21538
22. Pinto W. J., Srinivasan B., Shepherd S., Schmidt A., Dickson R. C. and Lester R. L. (1992) Sphingolipid long-chain-base auxotrophs of Saccharomyces cerevisiae: genetics, physiology, and a method for their selection. J. Bacteriol. 174: 2565-2574
23. Adachi-Yamada T., Gotoh T., Sugimura I., Tateno M., Nishida Y, Onuki T. et al. (1999) De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in Drosophila imaginal discs. Mol. Cell. Biol. 19: 7276-7286
24. Hanada K., Nishijima M., Fujita T. and Kobayashi S. (2000) Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells: a novel evaluation system using an SPT-defective mammalian cell mutant. Biochem. Pharmacol. 59: 1211-1216
25. Yamashita T., Wada R., Sasaki T., Deng C., Bierfreund U., Sandhoff K. et al. (1999) A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. USA 96: 9142-9147
26. Olivera A. and Spiegel S. (2001) Sphingosine kinase: a mediator of vital cellular functions. Prostaglandins 64: 123-134
27. Spiegel S. and Milstien S. (2002) Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277: 25851-25854
28. Hobson J. P., Rosenfeldt H. M., Barak L. S., Olivera A., Poulton S., Caron M. G. et al. (2001) Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291: 1800-1803
29. Benaud C., Oberst M., Hobson J. P., Spiegel S., Dickson R. B. and Lin C. Y. (2002) Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. J. Biol. Chem. 277: 10539-1546
30. Min J. K., Yoo H. S., Lee E. Y., Lee W. J. and Lee Y. M. (2002) Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal. Biochem. 303: 167-175
31. Andrieu N., Salvayre R. and Levade T. (1994) Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem. J. 303: 341-345
32. Olivera A., Rosenthal J. and Spiegel S. (1996) Effect of acidic phospholipids on sphingosine kinase. J. Biol. Chem. 60: 3440-3450
33. Olivera A., Barlow K. D. and Spiegel S. (2000) Assaying sphingosine kinase activity. Methods Enzymol. 311: 215-223
34. Zhang H., Desai N. N., Olivera A., Seki T., Brooker G. and Spiegel S. (1991) Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114: 155-167
35. Van Broklyn J. R., Lee M. J., Menzeleev R., Olivera A., Edsall L., Cuvillier O., et al. (1998) Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol. 142: 229-240
36. Delpy E., Hatem S. N., Andrieu N., Vaumas C., Henaff M., Rucker-Martin C. et al. (1999) Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes. Cardiovasc. Res. 43: 398-407
37. Brantley-Finley C., Lyle C.S., Du L., Goodwin M.E., Hall T., Szwedo D., et al. (2003) The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem. Pharmacol. 66: 459-469
38. Zhao D., Letterman J. and Schreiber B. M. (2001) Beta-migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on beta VLDL plus EGF-induced cell proliferation. J. Biol. Chem. 276: 30579-30588
39. Zilversmit D. B. (1979) Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485
40. Auge N., Negre-Salvayre A., Salvayre R. and Levade T. (2000) Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog. Lipid Res. 39: 207-229
41. Von Haefen C., Wieder T., Gillissen B., Starck L., Graupner V., Dorken B. et al. (2002) Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 21: 4009-4019
42. Takuwa Y., Okamoto H., Takuwa N., Gonda K., Sugimoto N. and Sakurada S. (2001) Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Mol. Cell. Endocrinol. 177: 3-11
43. Ryu Y., Takuwa N., Sugimoto N., Sakurada S., Usui S., Okamoto H. et al. (2002) Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ. Res. 90: 325-332
44. Idzko M., Panther E., Corinti S., Morelli A., Ferrari D., Herouy Y. et al. (2002) Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 16: 625-627
45. Hisano N., Yatomi Y., Satoh K., Akimoto S., Mitsumata M., Fujino M. A. et al. (1999) Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. Blood 93: 4293-4299
46. Xia P., Vadas M. A., Rye K. E., Barter P. J. and Gamble, J. R. (1999) High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway: a possible mechanism for protection against atherosclerosis by HDL. J. Biol. Chem. 274: 33143-33147
47. Kockx M. M. and Herman A. G. (2000) Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res. 45: 736-746
48. Sachinidis A., Seewald S., Epping P., Seul C., Ko Y. and Vetter H. (1997) The growth-promoting effect of low-density lipoprotein may be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway. Mol. Pharmacol. 52: 389-397
49. Yang C. M., Chiu C. T., Wang C. C., Chien C. S., Hsiao L. D., Lin C. C. et al. (2000) Activation of mitogen-activated protein kinase by oxidized low-density lipoprotein in canine cultured vascular smooth muscle cells. Cell. Signal. 12: 205-214